Alex J. Mann, MSc

hVIVO
London, England, United Kingdom

Disclosure(s): hVIVO: Employee

Presentation(s):

• 573 - CD388, a Novel Drug-Fc Conjugate (DFC), Demonstrates Prophylactic Activity in an Influenza Human Challenge Model

  Saturday, October 19, 2024
  2:21 PM – 2:39 PM US PT